PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Clinical trial NCT06161519 · RECRUITING
Trial details
- NCT number
- NCT06161519
- Sponsor
- National Cancer Institute (NCI)
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-31
- Primary completion
- 2028-11-14
- Enrollment
- 146
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.